Skip to main content
Mason Freeman, MD, Endocrinology, Boston, MA, Massachusetts General Hospital

MasonWrightFreemanMD

Endocrinology Boston, MA

Diabetes, Lipid Metabolism

Professor of Medicine Chief, Lipid Metabolism Unit

Dr. Freeman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Freeman's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1985 - 1985
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1984
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1979

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1981 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific Sessions
    CinCor Pharma Announces Late-Breaking Presentation of Phase 2 BrigHtn Data on Baxdrostat in Treatment-Resistant Hypertension at the 2022 American Heart Association Scientific SessionsNovember 8th, 2022
  • CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming American Society of Nephrology Kidney Week 2022
    CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming American Society of Nephrology Kidney Week 2022October 25th, 2022
  • CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
    CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension ResearchOctober 21st, 2022
  • Join now to see all

Grant Support

  • Analysis Of ABCA Transporter Function In Homologous Recombinant MiceNational Center For Research Resources2006–2009
  • Cell Biology Of ABCA1National Heart, Lung, And Blood Institute2002–2006
  • Genomic Analysis Of Stress And InflammationNational Heart, Lung, And Blood Institute2003–2004
  • Shared Microarray FacilityNational Heart, Lung, And Blood Institute2002–2004
  • Development And Characterization Of CD14 Deficient MiceNational Center For Research Resources2001–2004
  • Macrophage Scavenger Receptor In AtherosclerosisNational Heart, Lung, And Blood Institute2000–2003
  • Macrophaage Lipid Receptors In AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Core--Molecular/Cell BiologyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
  • Core--Molecular BiologyEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1999
  • Regulation Of Scavenger Receptors In AtherosclerosisNational Heart, Lung, And Blood Institute1990–1998

Hospital Affiliations